From the Clinical Knowledge Center

Insomnia in the News

The link between circadian rhythm disturbances, insomnia, and health issues is a prominent concern among sleep investigators. In the three widely divergent studies mentioned below we focus on emerging technology, possible links between insomnia and health, and a new treatment option for insomnia...

> Read entire article
> Back to top

Compass Questions™

> Back to top

Responses from Last Compass Questions™

In the 07.29.08 issue of Clinical Compass™, we asked three questions.

Question #1 was "How often do you talk to your patients about how much exercise they undertake?" and the neuroscienceCME learning community responded:
41% - Very often
37% - Often
13% - Occasionally
07% - Seldom
02% - Never

Question #2 was "How likely would you be to introduce patients to a diet and exercise program if education on such was made available to you?" and the neuroscienceCME learning community responded:
62% - Very likely
32% - Likely
05% - Unlikely
01% - Not at all

Question #3 was "How confident are you in measuring levels of fitness and weight in your patients, e.g., through lung function tests and calculating Body Mass Index?" and the neuroscienceCME learning community responded:
08% - Extremely confident
14% - Very confident
27% - Somewhat confident
51% - I would need education on assessing these levels
in my practice

> Back to top

New Schizophrenia/Bipolar Disorder Monograph Now Available!

Atypical Antipsychotics for Depressive Symptoms in Patients with Schizophrenia and Bipolar Disorder

Premiere Date: Wednesday, August 6, 2008
Credit Expiration Date: Thursday, August 6, 2009

Activity Goal
To review neurobiological and clinical evidence related to the pathophysiology, presentation, and management of bipolar depression, with a specific emphasis on atypical antipsychotics.

Learning Objectives
At the end of this CE activity, participants should be able to:

• Identify the commonalities between schizophrenia and bipolar disorder in terms of depressive symptomatology.
• Explain what is known about the neurobiological substrates underlying depression.
• Compare and contrast available antipsychotic medications with respect to their effects on depressive symptoms in schizophrenia and bipolar disorder.
• Translate data on neurobiology, dopamine receptor pharmacology, and iatrogenic effects of antipsychotics into individualized treatment plans for depressive symptoms in patients with schizophrenia or bipolar disorder.

Credit Information
This activity offers CE credit for:

• Physicians (ACCME/AMA PRA Category 1)
• Nurses (CNE)
• Pharmacists (ACPE)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.

> View activity details
> Back to top